Dr. Usman's Cardiology Notes

  Statin Recommendations in Chronic Kidney Disease Statin Recommendations in Chronic Kidney Disease (CKD) Why Statins Matter in CKD Patients with chronic kidney disease have a markedly increased risk of: Atherosclerotic cardiovascular disease (ASCVD) Myocardial infarction Stroke Cardiovascular mortality Statins reduce cardiovascular events in most CKD patients, especially in non-dialysis CKD. --- Who Should Receive Statins? 1. CKD Patients ≥50 Years Most adults with CKD aged ≥50 years should receive a statin regardless of baseline LDL level. Includes: CKD stages 1–5 not on dialysis eGFR <60 mL/min/1.73m² Albuminuria/proteinuria --- 2. CKD Patients 18–49 Years Statin therapy is recommended if one or more are present: Diabetes mellitus Known coronary artery disease Prior stroke Estimated 10-year ASCVD risk >10% Smoking Hypertension with high CV risk --- CKD Staging and Statin Use CKD Stage Statin Recommendation Stage 1–2 Treat similar to general population Stage 3–5 (non-dialys...

  Mitral Valve Prolapse (MVP): The Click Behind the Murmur Introduction Mitral Valve Prolapse (MVP) is one of the most common valvular heart abnormalities encountered in clinical practice. It occurs when one or both mitral valve leaflets bulge backward into the left atrium during systole. While many patients remain asymptomatic throughout life, others may develop palpitations, arrhythmias, mitral regurgitation, or rarely sudden cardiac death. With advancements in echocardiography, our understanding of MVP has evolved from a benign auscultatory curiosity to a clinically important structural heart disease with distinct phenotypes and risk profiles. --- Anatomy of the Mitral Valve The mitral valve apparatus consists of: Anterior and posterior mitral leaflets Mitral annulus Chordae tendineae Papillary muscles Left ventricular myocardium Proper coaptation of these structures ensures unidirectional blood flow from the left atrium to the left ventricle. In MVP, leaflet redundancy, myxomat...

  Chronic Thromboembolic Pulmonary Hypertension (CTEPH) – Key Points Definition Chronic obstruction of pulmonary arteries by organized thromboembolic material leading to persistent pulmonary hypertension and progressive right heart failure. Diagnostic Criteria After ≥3 months of effective anticoagulation: Mean pulmonary artery pressure (mPAP) >20 mmHg Pulmonary vascular resistance (PVR) >2 Wood units Pulmonary artery wedge pressure ≤15 mmHg Imaging evidence of chronic thromboembolic disease Pathophysiology Incomplete resolution of pulmonary emboli Fibrosis and organization of thrombus Small vessel arteriopathy develops over time Increased RV afterload → RV dysfunction/failure Risk Factors Previous pulmonary embolism/DVT Recurrent venous thromboembolism Splenectomy Ventriculoatrial shunts Chronic inflammatory disorders Antiphospholipid syndrome Infected pacemaker leads Malignancy Symptoms Progressive exertional dyspnea Fatigue Exercise intolerance Syncope/presyncope Chest disc...

 A ventricular ectopic beat spreads away from its site of origin through the myocardium. The ECG polarity depends on the direction of depolarization relative to a lead. If the electrical wavefront moves toward a lead → the QRS is positive. If it moves away from a lead → the QRS is negative. In PVCs or VT, the earliest activation begins at the ectopic focus. Therefore, leads “looking at” the site of origin see activation moving away from them, producing a predominantly negative QRS complex (QS or rS pattern). Example: A PVC arising from the right ventricle spreads mainly toward the left ventricle. Right precordial leads like V1 are near the origin and see activation moving away → negative QRS in V1. Left-sided leads may see activation moving toward them → positive QRS. This principle is used for VT localization: Negative inferior leads → inferiorly directed activation → superior origin. LBBB morphology VT usually originates in the right ventricle. RBBB morphology VT usually originat...

  Evaluation of mitral prosthetic valve stenosis. Evaluation of Mitral Prosthetic Valve Stenosis on Echocardiography Introduction Mitral valve replacement significantly improves symptoms and survival in patients with severe mitral valve disease. However, prosthetic mitral valves may eventually develop obstruction due to thrombosis, pannus formation, structural degeneration, calcification, or infective vegetations. Echocardiography remains the cornerstone for assessing prosthetic mitral valve function and detecting stenosis. Evaluating prosthetic mitral valve stenosis can be challenging because prosthetic valves normally produce higher gradients than native valves. A comprehensive approach using two-dimensional imaging, Doppler assessment, and comparison with baseline studies is essential. --- Causes of Prosthetic Mitral Valve Stenosis Common causes include: Prosthetic valve thrombosis Pannus ingrowth Structural valve degeneration Calcification of bioprosthetic leaflets Vegetations ...

Evaluation of aortic prosthetic valve stenosis When the Valve Becomes the Problem: Echocardiographic Evaluation of Aortic Prosthetic Valve Stenosis Aortic valve replacement can dramatically improve symptoms and survival in patients with severe aortic valve disease. However, even after successful valve implantation, prosthetic valves are not immune to complications. One of the most important and challenging problems is prosthetic valve stenosis. For echocardiographers and clinicians, evaluating a stenotic prosthetic aortic valve requires more than simply measuring gradients. Prosthetic valves naturally produce higher velocities than native valves, and distinguishing normal prosthetic hemodynamics from true obstruction can sometimes feel like solving a puzzle. This article reviews the practical echocardiographic approach to evaluating aortic prosthetic valve stenosis in a clear and clinically useful way. --- Understanding Prosthetic Valve Stenosis Prosthetic valve stenosis refers to obst...

The imbalance between tethering and closing forces results in secondary mitral regurgitation. Tug of War Inside the Heart: Understanding Secondary Mitral Regurgitation Secondary mitral regurgitation (SMR), also called functional mitral regurgitation, is not primarily a disease of the mitral valve leaflets themselves. Instead, it occurs due to distortion of left ventricular geometry, leading to an imbalance between tethering and closing forces of the mitral valve. --- What is Secondary Mitral Regurgitation? In secondary MR, the mitral valve leaflets are structurally normal, but the surrounding ventricular apparatus becomes abnormal. The left ventricle dilates or remodels, preventing proper leaflet coaptation during systole, resulting in backward leakage of blood from the left ventricle into the left atrium. Common causes include: Ischemic cardiomyopathy Dilated cardiomyopathy Chronic heart failure Left ventricular remodeling after myocardial infarction --- The Concept of Tethering vs Cl...